These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Prophylactic antifungal agents used after lung transplantation. Marino E; Gallagher JC Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260 [TBL] [Abstract][Full Text] [Related]
29. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Aris RM; Routh JC; LiPuma JJ; Heath DG; Gilligan PH Am J Respir Crit Care Med; 2001 Dec; 164(11):2102-6. PubMed ID: 11739142 [TBL] [Abstract][Full Text] [Related]
30. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center. Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis. Burcham P; Sarzynski L; Khalfoun S; Novak KJ; Miller JC; Tumin D; Hayes D Paediatr Drugs; 2017 Aug; 19(4):339-346. PubMed ID: 28547678 [TBL] [Abstract][Full Text] [Related]
32. Impact of burkholderia infection on lung transplantation in cystic fibrosis. Murray S; Charbeneau J; Marshall BC; LiPuma JJ Am J Respir Crit Care Med; 2008 Aug; 178(4):363-71. PubMed ID: 18535253 [TBL] [Abstract][Full Text] [Related]
33. Indications for lung resection surgery and lung transplant in South American children with cystic fibrosis. Villac Adde F; Vidal Campos S; de Oliveira Braga Teixeira RH; Rodrigues JC Paediatr Respir Rev; 2018 Jan; 25():37-42. PubMed ID: 28366682 [TBL] [Abstract][Full Text] [Related]
34. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Qvist T; Pressler T; Thomsen VO; Skov M; Iversen M; Katzenstein TL Transplant Proc; 2013; 45(1):342-5. PubMed ID: 23267788 [TBL] [Abstract][Full Text] [Related]
35. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. Taylor JL; Palmer SM J Heart Lung Transplant; 2006 Aug; 25(8):985-8. PubMed ID: 16890122 [TBL] [Abstract][Full Text] [Related]
36. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737 [TBL] [Abstract][Full Text] [Related]
37. Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation. Hollander FM; van Pierre DD; de Roos NM; van de Graaf EA; Iestra JA J Cyst Fibros; 2014 Mar; 13(2):212-8. PubMed ID: 24041590 [TBL] [Abstract][Full Text] [Related]
40. Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry. Melzi ML; Kelly DA; Colombo C; Jara P; Manzanares J; Colledan M; Strazzabosco M; DeLorenzo P; Valsecchi MG; Adam R; Gridelli B; Assael BM; ; ; Transpl Int; 2006 Sep; 19(9):726-31. PubMed ID: 16918533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]